Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kyriaki Katsiki
Observed names:
K Katsiki,
K. Katsiki,
Katsiki, Kyriaki
Institutions:
Academy of Athens,
Biomedical Research Foundation of the Academy of Athens
Observed institutions:
Democritus University of Thrace,
Academy of Athens,
Biomedical Research Foundation of the Academy of Athens,
University Hospital of Alexandroupolis
ORCID:
0009-0004-8498-5640
Observed ORCID:
0009-0004-8498-5640
OpenAlex ID:
A5045757801
Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
·
Cancer Research Communications
·
11
PDF
Comparative Analysis of the TCR Repertoire in Bone Marrow CD8 + T Cells From Patients With Acute Myeloid Leukemia, Myelodysplastic Neoplasms, and Chronic Myelomonocytic Leukemia
2025
·
Kyriaki Katsiki
, Athanasios Tasis
, et al.
·
European Journal of Immunology
·
1
PDF
Data from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
·
1
P742: Transcriptomic Analysis of Isolated Cd4+ and Cd8+ T Cells Reveals Differences in Tcr Repertoire in Patients With High Risk Mds Compared to Aml.
2022
·
K. Katsiki
, A. Tasis
, et al.
·
HemaSphere
·
1
PO:01:001 Epitranscriptome editing and transcriptome fragmentation set immune-related epigenetic memory of monocytes in human systemic lupus erythematosus (SLE)
2026
·
Ioannis Zampetakis
, Maria Eleni Nikolaou
, et al.
·
Lupus Science & Medicine
PDF
Author response for "Comparative Analysis of the TCR Repertoire in Bone Marrow CD8+ T Cells From Patients With Acute Myeloid Leukemia, Myelodysplastic Neoplasms, and Chronic Myelomonocytic Leukemia"
2025
·
Katsiki, Kyriaki
, Tasis, Athanasios
, et al.
·
Publons reviews and discussion
Supplementary Data from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2025
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Data sheet 3 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2025
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Data sheet 2 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2025
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Data sheet 1 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2025
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Author response for "Comparative Analysis of the TCR Repertoire in Bone Marrow CD8+ T Cells From Patients With Acute Myeloid Leukemia, Myelodysplastic Neoplasms, and Chronic Myelomonocytic Leukemia"
2025
·
Katsiki, Kyriaki
, Tasis, Athanasios
, et al.
·
Publons reviews and discussion
Data sheet 1 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2025
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Data sheet 3 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2025
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Data sheet 2 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2025
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Supplementary Data from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2025
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Data sheet 3 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Figure 3 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Figure 7 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Data sheet 1 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Figure 2 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Figure 4 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Data sheet 2 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Figure 1 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Figure 6 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Figure 5 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024
·
Athanasios Tasis
, Nikos E. Papaioannou
, et al.
Show more works
View as search
Works count:
31
Citation count:
14
H-index:
1
I10-index:
1
Year
Topic
Type